Literature DB >> 7143647

Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. Experience of an international collaborative group.

.   

Abstract

The association between circulating cholesterol level and ten-year cancer mortality was investigated in 61,567 men aged 40 to 69 years from 11 population studies in eight countries. Those dying of cancer within one year of cholesterol determination had mean cholesterol levels 24 to 35 mg/dL lower on the average than the rest of the men. For years 2 through 5 and 6 through 10, the inverse association diminished markedly, with differences in mean cholesterol levels of only 4 to 5 mg/dL and 2 mg/dL, respectively. Lung cancer mortality was inversely associated with cholesterol level only in the first year, and no significant association with colon cancer. These findings are consistent with the hypothesis that lower cholesterol levels in cancer decedents are due to the effect of undetected disease on cholesterol level.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143647     DOI: 10.1001/jama.1982.03330210035031

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

Review 1.  Low serum cholesterol increases the risk of noncardiovascular events: an antagonist viewpoint.

Authors:  P H Jones
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

Review 2.  Dietary recommendations for coronary heart disease prevention: implications for non-cardiovascular diseases.

Authors:  B Lewis
Journal:  Z Ernahrungswiss       Date:  1983-09

Review 3.  Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.

Authors:  K J Lackner; G Schettler; W Kübler
Journal:  Klin Wochenschr       Date:  1989-09-15

Review 4.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

5.  Premature mortality in middle-aged men: serum cholesterol as risk factor.

Authors:  B Peterson; E Trell
Journal:  Klin Wochenschr       Date:  1983-08-15

6.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

7.  Elevated lipoprotein(a) levels in patients with acute myeloblastic leukaemia decrease after successful chemotherapeutic treatment.

Authors:  A Niendorf; A Stang; U Beisiegel; A Peters; H Nägele; A Gebhardt; R Kuse
Journal:  Clin Investig       Date:  1992-08

8.  Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study.

Authors:  A M Strasak; R M Pfeiffer; L J Brant; K Rapp; W Hilbe; W Oberaigner; S Lang; W Borena; H Concin; G Diem; E Ruttmann; B Glodny; K P Pfeiffer; H Ulmer
Journal:  Ann Oncol       Date:  2009-01-22       Impact factor: 32.976

9.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

10.  A Mendelian randomization analysis of circulating lipid traits and breast cancer risk.

Authors:  Alicia Beeghly-Fadiel; Nikhil K Khankari; Ryan J Delahanty; Xiao-Ou Shu; Yingchang Lu; Marjanka K Schmidt; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Joe Dennis; Drakoulis Yannoukakos; Alison M Dunning; Paul D P Pharoah; Georgia Chenevix-Trench; Roger L Milne; David J Hunter; Hall Per; Peter Kraft; Jacques Simard; Douglas F Easton; Wei Zheng
Journal:  Int J Epidemiol       Date:  2020-08-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.